McKay Robert A 4
4 · PharMerica CORP · Filed Dec 8, 2017
Insider Transaction Report
Form 4
McKay Robert A
SVP of Sales and Marketing
Transactions
- Disposition to Issuer
Common Stock, $0.01 par value
2017-12-07$29.25/sh−89,314$2,612,435→ 0 total
Footnotes (1)
- [F1]Pursuant to the terms of the Agreement and Plan of Merger, dated as of August 1, 2017 (the "Merger Agreement"), by and among PharMerica Corporation (the "Company"), Phoenix Parent Holdings Inc., a Delaware corporation ("Parent"), and Phoenix Merger Sub Inc., a Delaware corporation and wholly owned subsidiary of Parent, at the effective time ("Effective Time") of the merger of Merger Sub with and into the Company, with the Company as the surviving entity and a wholly owned subsidiary of Parent, each share of the Company's common stock, par value $0.01 per share ("Company Common Stock") owned by the reporting person was converted into the right to receive $29.25 in cash without interest (the "Merger Consideration").